New York, New York, November 16th, 2026, FinanceWire The collaboration connects Injective’s financial blockchain infrastructure with the University of Tokyo’s expertise in blockchain research and […]
Read moreINmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
Boca Raton, Florida, October 21st, 2026, FinanceWire Final pre-MAA package submitted to MHRA on October 20, 2026 Full MAA submission targeted for early February 2027, under a revised strategy that could bring potential UK approval forward by approximately six weeks […]
Read more